International Stem Cell Corp. (ISCO) Secures $10.25 Million Stock Purchase Agreement at Low Cost of Capital
Today before the opening bell, International Stem Cell announced that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"), a Chicago-based institutional investor, which has agreed to invest up to $10.25 million of the company’s common stock over a 36-month term. "We are pleased to have this new financing arrangement in place with Lincoln Park Capital," said Dr. Andrey Semechkin, CEO and Co-Chairman. "The agreement gives us access to a significant new source of funding, strengthens our balance sheet, and provides us the flexibility we have been looking for at a low cost of capital."…